With deep clinical trial expertise and a consultative approach, the PharPoint team can provide strategic support to help guide pharmaceutical, biotechnology, and medical device companies as they develop their drug development programs from pre-IND planning through regulatory approval.
Work with our experts for IND submission support, strategic development planning and maintenance, and program review.
Partner with regulatory experts to lay out a pathway to approval, including strategy development and review, expedited pathway exploration, and regulatory meeting support and representation.
Is your team prepared for ICH E6(R3)? Work with a consultant to assess your current status and build practical, organization-wide changes that support a shift toward proactive, risk-based quality.
Our quality consultants have deep expertise within GxP and can help sponsors assess current workflows, identify risk areas, and guide teams through practical improvements.
Get Phase 1-4 trial support, including protocol design, risk mitigation, Key Opinion Leader (KOL) network development, or investigative site feasibility.

Everyone talks about “quality culture.” But can you be certain your team and vendors have it? Discover the practical indicators that separate the buzz from the real thing.
→ Read: Evaluating Quality Culture in Clinical Research: Beyond the Buzzword
Related Resources